Alternate choice of initiation codon produces a biologically active product of the von Hippel Lindau gene with tumor suppressor activity

被引:101
作者
Blankenship, C
Naglich, JG
Whaley, JM
Seizinger, B
Kley, N
机构
[1] Genome Therapeut Corp, Dept Funct Genom, Waltham, MA 02154 USA
[2] Bristol Myers Squibb Pharmaceut Res Inst, Dept Oncol, Princeton, NJ 08540 USA
[3] Bristol Myers Squibb Pharmaceut Res Inst, Dept Metab Dis, Princeton, NJ 08540 USA
关键词
pVHL; VEGF; elongins; Hs-CUL2;
D O I
10.1038/sj.onc.1202473
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The VHL tumor suppressor gene has previously been reported to encode a protein of 213 amino acid residues. Here we report the identification of a second major VHL gene product with an apparent molecular weight of 18 kD, pVHL18, which appears to arise from alternate translation initiation at a second AUG codon (codon 54) within the VHL open reading frame. In vitro and in vivo studies indicate that the internal codon in the VHL mRNA is necessary and sufficient for production of pVHL18. pVHL18 can bind to elongin B, elongin C, and Hs-CUL2, When reintroduced into renal carcinoma cells that lack a wild-type VHL allele, pVHL18 suppresses basal levels of VEGF expression, restores hypoxia-inducibility of VEGF expression, and inhibits tumor formation in nude mice. These data strongly support the existence of two distinct VHL gene products in VHL tumor suppression.
引用
收藏
页码:1529 / 1535
页数:7
相关论文
共 33 条
[1]
SUBCELLULAR FATE OF THE INT-2 ONCOPROTEIN IS DETERMINED BY CHOICE OF INITIATION CODON [J].
ACLAND, P ;
DIXON, M ;
PETERS, G ;
DICKSON, C .
NATURE, 1990, 343 (6259) :662-665
[2]
[Anonymous], 1988, Antibodies: A Laboratory Manual
[3]
INDUCTION OF THE GROWTH INHIBITOR IGF-BINDING PROTEIN-3 BY P53 [J].
BUCKBINDER, L ;
TALBOTT, R ;
VELASCOMIGUEL, S ;
TAKENAKA, I ;
FAHA, B ;
SEIZINGER, BR ;
KLEY, N .
NATURE, 1995, 377 (6550) :646-649
[4]
Immunostaining of the von Hippel-Lindau gene product in normal and neoplastic human tissues [J].
Corless, CL ;
Kibel, AS ;
Iliopoulos, O ;
Kaelin, WG .
HUMAN PATHOLOGY, 1997, 28 (04) :459-464
[5]
INHIBITION OF TRANSCRIPTION ELONGATION BY THE VHL TUMOR-SUPPRESSOR PROTEIN [J].
DUAN, DR ;
PAUSE, A ;
BURGESS, WH ;
ASO, T ;
CHEN, DYT ;
GARRETT, KP ;
CONAWAY, RC ;
CONAWAY, JW ;
LINEHAN, WM ;
KLAUSNER, RD .
SCIENCE, 1995, 269 (5229) :1402-1406
[6]
CHARACTERIZATION OF THE VHL TUMOR-SUPPRESSOR GENE-PRODUCT - LOCALIZATION, COMPLEX-FORMATION, AND THE EFFECT OF NATURAL INACTIVATING MUTATIONS [J].
DUAN, DR ;
HUMPHREY, JS ;
CHEN, DYT ;
WENG, YK ;
SUKEGAWA, J ;
LEE, S ;
GNARRA, JR ;
LINEHAN, WM ;
KLAUSNER, RD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (14) :6459-6463
[7]
GAO JZ, 1995, CANCER RES, V55, P743
[8]
MOD5 TRANSLATION INITIATION SITES DETERMINE N6- ISOPENTENYLADENOSINE MODIFICATION OF MITOCHONDRIAL AND CYTOPLASMIC TRANSFER-RNA [J].
GILLMAN, EC ;
SLUSHER, LB ;
MARTIN, NC ;
HOPPER, AK .
MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (05) :2382-2390
[9]
MUTATIONS OF THE VHL TUMOR-SUPPRESSOR GENE IN RENAL-CARCINOMA [J].
GNARRA, JR ;
TORY, K ;
WENG, Y ;
SCHMIDT, L ;
WEI, MH ;
LI, H ;
LATIF, F ;
LIU, S ;
CHEN, F ;
DUH, FM ;
LUBENSKY, I ;
DUAN, DR ;
FLORENCE, C ;
POZZATTI, R ;
WALTHER, MM ;
BANDER, NH ;
GROSSMAN, HB ;
BRAUCH, H ;
POMER, S ;
BROOKS, JD ;
ISAACS, WB ;
LERMAN, MI ;
ZBAR, B ;
LINEHAN, WM .
NATURE GENETICS, 1994, 7 (01) :85-90
[10]
Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene [J].
Gnarra, JR ;
Zhou, SB ;
Merrill, MJ ;
Wagner, JR ;
Krumm, A ;
Papavassiliou, E ;
Oldfield, EH ;
Klausner, RD ;
Linehan, WM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (20) :10589-10594